Jade Biosciences earnings were -$49.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest JBIO earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$2.5M, down 53.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, JBIO reported annual earnings of -$69.6M, with -7.8% growth.
What were Jade Biosciences's earnings last quarter?
Jade Biosciences (NASDAQ: JBIO) reported Q1 2025 earnings per share (EPS) of -$3.15, up 89.16% year over year. Total JBIO earnings for the quarter were -$2.52 million. In the same quarter last year, Jade Biosciences's earnings per share (EPS) was -$29.05.
As of the last Jade Biosciences earnings report, Jade Biosciences is currently losing money. Jade Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$48.96 million, a 40.43% decrease year over year.
What was JBIO's earnings growth in the past year?
As of Jade Biosciences's earnings date in Q2 2025, Jade Biosciences's earnings has grown year over year. JBIO earnings in the past year totalled -$48.96 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.